Updates in Psoriatic Arthritis - On Demand Webinar
Hear from national experts in this one hour webinar program that addresses the latest updates in psoriatic arthritis including latest biologic treatments, burden of disease, comorbidites and much more.
This activity has been supported by unrestricted educational grants from Valeant, Novartis, and Abbvie.
If you do not yet have an account with the national psoriasis foundation, please click here to create a new account prior to taking this course. Thank you!
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Psoriasis Foundation designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Dermatologists, Rheumatologists, Allied Health, Primary Care
- Discuss the efficacy and safety of newly approved and promising pipeline therapies for psoriatic arthritis, including biologics, small molecule inhibitors, and IL-17 blockade, and how they target various points in the inflammatory pathway.
- Assess the burden of psoriatic arthritis beyond the skin, including associated co-morbid conditions and psychosocial effects
- Discuss the efficacy, safety and appropriate use of the topical, systemic and biologic therapies currently available for the treatment of psoriatic arthritis
Philip Mease, MD
Director, Rheumatology Research
Swedish Medical Center
University of Washington School of Medicine
Elaine Husni, MD, MPH
Vice Chair of Rheumatology
Director, Arthritis and Musculoskeletal Center
Assistant Professor, Cleveland Clinic Lerner College of Medicine